The Rs1550117 A>G Variant in DNMT3A Gene Promoter Significantly Increases Non-Small Cell Lung Cancer Susceptibility in a Han Chinese Population

Jingdong Wang,Chade Li,Fengting Wan,Zhou Li,Jingli Zhang,Jiankun Zhang,Xianhong Feng,Liang Tang,Bifeng Chen
DOI: https://doi.org/10.18632/oncotarget.15625
2017-01-01
Oncotarget
Abstract:In this study, we conducted a case-control study to explore the association between rs1550117 A>G variant of DNMT3A gene promoter and non-small cell lung cancer (NSCLC) susceptibility in a Han Chinese population. The genotyping of rs1550117 A>G variant was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and confirmed by sequencing. Allele G of rs1550117 was associated with an increased risk of NSCLC. Moreover, individuals carrying the GG genotypes had a higher risk to develop NSCLC than the AA and GA genotype carriers. Further stratified analysis showed that rs1550117 A>G was significantly related to age (> 60 years), male, smoking and drinking. In vivo detection of DNMT3A mRNA levels in NSCLC tissues and in vitro luciferase assays consistently showed that the allele G significantly decreased DNMT3A transcription. Additional functional analysis revealed that the increased binding affinity of transcription repressor SP1, which was associated with allele G of rs1550117, led to the significant decreased expression of DNMT3A. Collectively, our results propose a suppression role of DNMT3A in NSCLC development and emphasize the dual roles of DNMT3A in tumorigenesis.
What problem does this paper attempt to address?